Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae
- 30 November 2004
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (3) , 213-217
- https://doi.org/10.1016/j.diagmicrobio.2004.07.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Quinolone Resistance among Pneumococci: Therapeutic and Diagnostic ImplicationsClinical Infectious Diseases, 2004
- Quinolone Resistance Mechanisms in PneumococciClinical Infectious Diseases, 2004
- Pharmacodynamics of the New Des-F(6)-QuinoloneGarenoxacin in a Murine Thigh InfectionModelAntimicrobial Agents and Chemotherapy, 2003
- Activities of Mutant Prevention Concentration-Targeted Moxifloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2003
- Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2003
- Pharmacodynamics of a Novel Des-F(6)-Quinolone, BMS-284756, against Streptococcus pneumoniae in the Thigh Infection ModelAntimicrobial Agents and Chemotherapy, 2003
- Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United StatesNature Medicine, 2003
- Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjectsJournal of Antimicrobial Chemotherapy, 2003
- Comparative Bactericidal Activity of Fluoroquinolones Against Clinical Isolates Resistant to FluoroquinolonesJournal of Chemotherapy, 2003
- Assessment of BMS284756 MIC and 5-μg disk diffusion quality control studies tested against seven American type culture collection strainsDiagnostic Microbiology and Infectious Disease, 2001